Dolutegravir

AntiHum HLA-DOB,FITC,(clone:DOB 10E6/5,Mse IgG1)100ug

AntiHum HLA-DOB,Pure,(clone:DOB 10E6/5,Mse IgG1)200ug

InformationBictegravir (GS-9883) is a novel, potent, once-daily, unboosted inhibitor ofHIV-1 integrase.TargetsHIV-1 integraseIn vitroBictegravir exhibits potent and selective in vitro antiretroviral activity in both T-cell lines and primary human T

InformationBictegravir (GS-9883) is a novel, potent, once-daily, unboosted inhibitor ofHIV-1 integrase.TargetsHIV-1 integraseIn vitroBictegravir exhibits potent and selective in vitro antiretroviral activity in both T-cell lines and primary human T

InformationBictegravir (GS-9883) is a novel, potent, once-daily, unboosted inhibitor ofHIV-1 integrase.TargetsHIV-1 integraseIn vitroBictegravir exhibits potent and selective in vitro antiretroviral activity in both T-cell lines and primary human T

InformationBictegravir (GS-9883) is a novel, potent, once-daily, unboosted inhibitor ofHIV-1 integrase.TargetsHIV-1 integraseIn vitroBictegravir exhibits potent and selective in vitro antiretroviral activity in both T-cell lines and primary human T

InformationDolutegravir (GSK1349572) Dolutegravir (GSK1349572, S/GSK1349572) is a two-metal-binding HIV integrase inhibitor with IC50 of 2.7 nM in a cell-free assay, modest activity against raltegravir-resistant signature mutants Y143R, Q148K,

Dolutegravir intermediate-1 .

Dolutegravir intermediate-1 .

Dovitinib

Dovitinib

EXO-HSO-04-L HIVIZ UTILITY GLVLGE HI VIZ ORANGE